Recent advances in the development of neuroprotective agents and therapeutic targets in the treatment of cerebral ischemia
Y Luo, H Tang, H Li, R Zhao, Q Huang, J Liu - European journal of …, 2019 - Elsevier
Stroke is a central nervous system disease that seriously affects people's quality of life and
has the second highest rate of morbidity and mortality in the world. At present, clinical …
has the second highest rate of morbidity and mortality in the world. At present, clinical …
Recent advances in the development of neuroprotective agents and therapeutic targets in the treatment of cerebral ischemia
Y Luo, H Tang, H Li, R Zhao… - European journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Stroke is a central nervous system disease that seriously affects people's quality of life and
has the second highest rate of morbidity and mortality in the world. At present, clinical …
has the second highest rate of morbidity and mortality in the world. At present, clinical …
[引用][C] Recent advances in the development of neuroprotective agents and therapeutic targets in the treatment of cerebral ischemia
Y Luo, H Tang, H Li, R Zhao, Q Huang… - European Journal of …, 2019 - cir.nii.ac.jp
Recent advances in the development of neuroprotective agents and therapeutic targets in the
treatment of cerebral ischemia | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
treatment of cerebral ischemia | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Recent advances in the development of neuroprotective agents and therapeutic targets in the treatment of cerebral ischemia.
Y Luo, H Tang, H Li, R Zhao, Q Huang… - European Journal of …, 2018 - europepmc.org
Stroke is a central nervous system disease that seriously affects people's quality of life and
has the second highest rate of morbidity and mortality in the world. At present, clinical …
has the second highest rate of morbidity and mortality in the world. At present, clinical …